Seller record · dudemeds.com
DudeMeds
Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The terms reach only a consent authorizing DudeMeds pharmacy partners to provide products, which identifies no facility. 2 more criteria also fail; see the table below.
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A men's telehealth service selling semaglutide and tirzepatide for weight loss, prescription NAD+ for anti-aging, and testosterone therapy. It publishes a starting price for each category and never states whether the medication it ships is compounded.
Operating entity DudeMeds LLC
Dispositions
| Code | Criterion | Disposition | Where it was read |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | dudemeds.com/weight-loss |
| S2 | Prescription gating | PASS | dudemeds.com/weight-loss/patient-type |
| S3 | Pharmacy identification | FAIL | dudemeds.com/legal/terms-and-conditions |
| S4 | Compounding disclosure | FAIL | dudemeds.com/weight-loss |
| S5 | Analytical documentation | FAIL | dudemeds.com |
| S6 | Business address | PASS | dudemeds.com/contact-us |
| S7 | Price disclosure | PASS | dudemeds.com/weight-loss |
| S8 | Enforcement status | PASS | fda.gov |
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
Products shown on the seller's own pages at the recorded date: semaglutide, oral and injectable, tirzepatide, oral and injectable, prescription NAD+, testosterone replacement therapy, hair, skin and sexual health medications.
Partner link. The site earns a commission on care started through it. Funding.
Visit DudeMedsDispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.